| Hurricanes and healthcare: a case report on the influences of Hurricane Maria and managed Medicare in treating a Puerto Rican resident G Mellgard, D Abramson, C Okamura, H Weerahandi BMC health services research 19, 1-5, 2019 | 19 | 2019 |
| The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer NJ Shah, VG Patel, X Zhong, L Pina, JE Hawley, E Lin, BA Gartrell, ... JNCI cancer spectrum 6 (3), pkac035, 2022 | 10 | 2022 |
| The role of androgen deprivation therapy on the clinical course of COVID-19 infection in men with prostate cancer. VG Patel, X Zhong, NJ Shah, L Pina Martina, J Hawley, E Lin, BA Gartrell, ... Journal of Clinical Oncology 39 (6_suppl), 41-41, 2021 | 8 | 2021 |
| Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors. Q Qin, VG Patel, B Wang, G Mellgard, M Gogerly-Moragoda, X Zhong, ... Journal of Clinical Oncology 38 (15_suppl), e15160-e15160, 2020 | 8 | 2020 |
| Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors G Mellgard, VG Patel, X Zhong, H Joshi, Q Qin, B Wang, A Parikh, T Jun, ... Journal of Cancer Research and Clinical Oncology 149 (7), 2833-2841, 2023 | 5 | 2023 |
| Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis Q Qin, T Jun, B Wang, VG Patel, G Mellgard, X Zhong, ... Discover Oncology 13 (1), 73, 2022 | 5 | 2022 |
| Complexity, not severity: Reinterpreting the sliding scale of capacity G Mellgard, N Gligorov Cambridge Quarterly of Healthcare Ethics 31 (4), 506-517, 2022 | 4 | 2022 |
| Examining variation in state spending on medicaid long-term services and supports for older adults G Mellgard, C Ankuda, OK Rahman, A Kelley Home health care services quarterly 41 (1), 54-64, 2022 | 3 | 2022 |
| Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy AB Parikh, X Zhong, G Mellgard, Q Qin, VG Patel, B Wang, P Alerasool, ... American journal of clinical oncology 44 (3), 114-120, 2021 | 3 | 2021 |
| Lessons from withdrawn accelerated approvals in oncology GS Mellgard, T Fojo, SE Bates Nature Cancer, 1-5, 2024 | 1 | 2024 |
| How Are We Doing? A Scoping Review of Published Patient-Centered Outcomes Research in United States Student-Run Free Clinics F Silvestri, G Mellgard, J Goldstein, S Chennareddy, J Tang, M Tran, ... Teaching and Learning in Medicine, 1-13, 2023 | 1 | 2023 |
| Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors. VG Patel, Q Qin, B Wang, M Gogerly-Moragoda, G Mellgard, X Zhong, ... Journal of Clinical Oncology 38 (15_suppl), e15068-e15068, 2020 | 1 | 2020 |
| Smoking status and immunotherapy outcomes in smoking-associated cancers. T Jun, T Ganta, Q Qin, VG Patel, B Wang, G Mellgard, ... Journal of Clinical Oncology 38 (15_suppl), e15097-e15097, 2020 | 1 | 2020 |
| Evaluation of patient health outcomes of a student-run free clinic in East Harlem JJ Jiang, K Link, G Mellgard, F Silvestri, D Qian, S Chennareddy, M Tran, ... BMC Medical Education 24 (1), 323, 2024 | | 2024 |
| Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma G Mellgard, M Gilligan, ERS Cliff, D Bhutani, GR Mohyuddin, ... HemaSphere 8 (3), 2024 | | 2024 |
| Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor–targeted Therapy Z Chakrani, G Mellgard, N Saffran, S McCroskery, N Taylor, M Patel, ... American Journal of Clinical Oncology, 10.1097, 2024 | | 2024 |
| Risk Stratification Models Overestimate Progression Risk in Contemporary Patients with Smoldering Multiple Myeloma (SMM) G Mellgard, M Gilligan, ERS Cliff, D Bhutani, GR Mohyuddin, ... Blood 142, 4768, 2023 | | 2023 |
| Performance status and end-of-life outcomes in patients with metastatic castration resistant prostate cancer treated with androgen receptor targeted therapy G Mellgard, N Saffran, Z Chakrani, S McCroskery, N Taylor, M Patel, ... | | 2023 |
| Survival outcomes and toxicity in older adults with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted (ART) therapies. GS Mellgard, Z Chakrani, S Mccroskery, N Saffran, N Taylor, BCH Liaw, ... Journal of Clinical Oncology 41 (6_suppl), 117-117, 2023 | | 2023 |
| The effect of statin use on survival outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted therapies (ART). GS Mellgard, N Saffran, Z Chakrani, S Mccroskery, N Taylor, BCH Liaw, ... Journal of Clinical Oncology 41 (6_suppl), 194-194, 2023 | | 2023 |
